Insider Transactions in Q4 2024 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
15,000
-2.25%
|
$1,350,000
$90.1 P/Share
|
|
Dec 19
2024
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.0%
|
$540,000
$36.05 P/Share
|
|
Dec 18
2024
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-1.59%
|
$218,304
$96.19 P/Share
|
|
Dec 12
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,819
-5.56%
|
$169,167
$93.43 P/Share
|
|
Dec 12
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+8.7%
|
$24,000
$15.01 P/Share
|
|
Nov 29
2024
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,353
-0.51%
|
$225,888
$96.63 P/Share
|
|
Nov 27
2024
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-3.08%
|
$216,030
$95.1 P/Share
|
|
Nov 21
2024
|
Lonnel Coats |
SELL
Open market or private sale
|
Direct |
9,824
-81.42%
|
$923,456
$94.87 P/Share
|
|
Nov 20
2024
|
Lonnel Coats |
SELL
Open market or private sale
|
Direct |
10,000
-17.41%
|
$940,000
$94.13 P/Share
|
|
Nov 20
2024
|
Lonnel Coats |
BUY
Exercise of conversion of derivative security
|
Direct |
8,812
+16.08%
|
$643,276
$73.01 P/Share
|
|
Nov 07
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-3.08%
|
$510,000
$102.0 P/Share
|
|
Nov 07
2024
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.98%
|
$180,000
$36.05 P/Share
|
|
Oct 03
2024
|
Fouad Namouni PRESIDENT, R & D |
SELL
Open market or private sale
|
Direct |
3,633
-5.0%
|
$323,337
$89.32 P/Share
|